LOADING
Comparing Procter & Gamble (PG) and AbbVie Inc (ABBV) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $352.6B | $388.4B |
| P/E Ratio | 22.3 | 92.7 |
| Forward P/E | 20.5 | 15.1 |
| PEG Ratio | 4.10 | 0.52 |
| EPS | $6.75 | $2.37 |
| Revenue Growth (YoY) | 1.5% | 10.0% |
| Profit Margin | 19.3% | 6.9% |
| Return on Equity | 31.6% | 62.3% |
| Dividend Yield | 2.78% | 2.95% |
| Beta | 0.34 | 0.33 |
| 52-Week High | $170.10 | $241.12 |
| 52-Week Low | $136.65 | $159.05 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.